Gland Pharma Limited
Promoter holding in Gland Pharma Limited was 51.77% in Jun 2026, down 0.06 points from the previous quarter. Since Sep 2024 it has fallen 0.06 points.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Jun '26 | 51.77%▼0.06 | 48.23%▲0.06 |
| Mar '26 | 51.83%=0.00 | 48.17%=0.00 |
| Dec '25 | 51.83%=0.00 | 48.17%=0.00 |
| Sep '25 | 51.83%=0.00 | 48.17%=0.00 |
| Jun '25 | 51.83%=0.00 | 48.17%=0.00 |
| Mar '25 | 51.83%=0.00 | 48.17%=0.00 |
| Dec '24 | 51.83%=0.00 | 48.17%=0.00 |
| Sep '24 | 51.83%=0.00 | 48.17%=0.00 |
Trend
- Over a longer period, promoter holding went from 58.02% in Sep 2021 to 51.77% in Jun 2026, down 6.25 points.
- Of the last 8 quarterly changes on record, promoter holding fell in 1 and stayed the same in 7.
- The largest quarterly change was a fall of 0.06 points in the quarter to Jun 2026.
Compared with similar companies
Promoter holding in Gland Pharma Limited is lower than 56% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Gland Pharma Limited | 51.77% |
| Ipca Laboratories Limited | 44.72% |
| Anthem Biosciences Limited | 71.42% |
| GlaxoSmithKline Pharmaceuticals Limited | 75.00% |
| Abbott India Limited | 74.99% |
| Biocon Limited | 44.68% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Gland Pharma Limited's promoter holding?
Promoters held 51.77% of Gland Pharma Limited as of 30 Jun 2026, and the public held 48.23%.
Has Gland Pharma Limited's promoter holding increased?
No, it fell by 0.06 percentage points in the quarter to Jun 2026.
Are any promoter shares of Gland Pharma Limited pledged?
No promoter shares are recorded as pledged.
How has Gland Pharma Limited's promoter holding changed over the years?
Over a longer period, promoter holding went from 58.02% in Sep 2021 to 51.77% in Jun 2026, down 6.25 points.
How does Gland Pharma Limited's promoter holding compare with similar companies?
Promoter holding in Gland Pharma Limited is lower than 56% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.